[Do elderly patients benefit from recent advances in the treatment of ischemic heart disease?]

Kazumasa Harada1

  • 1Department of Cardiology, Tokyo Metropolitan Geriatric Hospital, Japan.

Insights

Emergency percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) in elderly patients shows improved survival rates compared to conservative treatment. Optimal medication and stent choice are crucial for long-term prognosis in this population.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Context:

  • Elderly patients with ischemic heart disease often present unique challenges for percutaneous coronary intervention (PCI).
  • Acute coronary syndrome (ACS) management in the very elderly requires careful consideration of risks and benefits.
  • Transradial approach for PCI is feasible in elderly individuals.

Purpose:

  • To evaluate the outcomes of emergency PCI in elderly patients with ACS.
  • To identify factors associated with in-hospital and long-term adverse events after PCI in older adults.
  • To compare the prognosis of elderly patients undergoing emergency PCI versus those not receiving it.

Summary:

  • Emergency PCI for ACS in elderly patients (66-98 years) demonstrated significantly lower mortality (4.6%-7.3%) compared to non-PCI management (20%).
  • In-hospital events were linked to anemia, CRP, max CK-MB, and vessel involvement. Long-term prognosis correlated with max CK-MB and renal function.
  • Indications for emergency PCI in the elderly should mirror those in younger patients, despite challenges like ambiguous symptoms, dementia, and renal dysfunction. Drug-eluting stents showed better mid-term outcomes than bare-metal stents, although bare-metal stents may be preferable in ACS cases.

Impact:

  • Emergency PCI is a viable and beneficial treatment for elderly patients with ACS, improving survival rates.
  • Understanding prognostic factors allows for tailored management strategies to optimize outcomes in older adults post-PCI.
  • Further research into optimal stent selection and management of comorbidities is warranted for this growing patient population.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...